| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 |
| filingDate |
2001-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44b2ab1f8ecc04eebfe47961c2945149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c799fedda4c31670e31747a84ab1b5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791fe559b4c0527fe09fbeec41f00f45 |
| publicationDate |
2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2001041739-A1 |
| titleOfInvention |
Use of PDE-4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection |
| abstract |
This invention relates to a method for the prophylaxis of or reducing the severity of post-viral bacterial infection by administering a PDE 4-specific inhibitor prior to or during the course of a viral infection or thereafter during the course of the bacterial infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9408831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010095041-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011127019-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008006051-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008006052-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010095041-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008006051-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008006052-A3 |
| priorityDate |
2000-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |